GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Merck & Co Inc (BUE:MRK) » Definitions » Shiller PE Ratio

Merck (BUE:MRK) Shiller PE Ratio : 43.36 (As of Apr. 30, 2024)


View and export this data going back to . Start your Free Trial

What is Merck Shiller PE Ratio?

As of today (2024-04-30), Merck's current share price is ARS28373.00. Merck's E10 for the quarter that ended in Dec. 2023 was ARS654.40. Merck's Shiller PE Ratio for today is 43.36.

The historical rank and industry rank for Merck's Shiller PE Ratio or its related term are showing as below:

BUE:MRK' s Shiller PE Ratio Range Over the Past 10 Years
Min: 17.67   Med: 26.85   Max: 39.37
Current: 38.65

During the past years, Merck's highest Shiller PE Ratio was 39.37. The lowest was 17.67. And the median was 26.85.

BUE:MRK's Shiller PE Ratio is ranked worse than
72.57% of 525 companies
in the Drug Manufacturers industry
Industry Median: 24.85 vs BUE:MRK: 38.65

E10 is a concept invented by Prof. Robert Shiller, who uses E10 for his Shiller PE Ratio calculation. E10 is the average of the inflation adjusted earnings of a company over the past 10 years.

Merck's adjusted earnings per share data for the three months ended in Dec. 2023 was ARS-1,732.800. Add all the adjusted EPS for the past 10 years together and divide 10 will get our E10, which is ARS654.40 for the trailing ten years ended in Dec. 2023.

Shiller PE for Stocks: The True Measure of Stock Valuation


Merck Shiller PE Ratio Historical Data

The historical data trend for Merck's Shiller PE Ratio can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Merck Shiller PE Ratio Chart

Merck Annual Data
Trend Dec14 Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23
Shiller PE Ratio
Get a 7-Day Free Trial Premium Member Only Premium Member Only 39.15 31.30 26.05 32.35 32.38

Merck Quarterly Data
Jun19 Sep19 Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24
Shiller PE Ratio Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 30.13 35.01 29.75 32.38 -

Competitive Comparison of Merck's Shiller PE Ratio

For the Drug Manufacturers - General subindustry, Merck's Shiller PE Ratio, along with its competitors' market caps and Shiller PE Ratio data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Merck's Shiller PE Ratio Distribution in the Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, Merck's Shiller PE Ratio distribution charts can be found below:

* The bar in red indicates where Merck's Shiller PE Ratio falls into.



Merck Shiller PE Ratio Calculation

For Shiller PE Ratio, the earnings of the past 10 years are inflation-adjusted and averaged. The result is used for P/E calculation. Since it looks at the average over the last 10 years, the Shiller PE Ratio is also called PE10.

The Shiller PE Ratio was first used by professor Robert Shiller to measure the valuation of the overall market. The same calculation is applied here to individual companies.

Merck's Shiller PE Ratio for today is calculated as

Shiller PE Ratio=Share Price/ E10
=28373.00/654.4
=43.36

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Merck's E10 for the quarter that ended in Dec. 2023 is calculated as:

For example, Merck's adjusted earnings per share data for the three months ended in Dec. 2023 was:

Adj_EPS=Earnings per Share (Diluted)/CPI of Dec. 2023 (Change)*Current CPI (Dec. 2023)
=-1732.8/129.4194*129.4194
=-1,732.800

Current CPI (Dec. 2023) = 129.4194.

Merck Quarterly Data

Earnings per Share (Diluted) CPI Adj_EPS
201403 45.195 99.695 58.670
201406 55.250 100.560 71.106
201409 26.099 100.428 33.633
201412 217.195 99.070 283.732
201503 29.105 99.621 37.811
201506 21.808 100.684 28.032
201509 60.175 100.392 77.574
201512 45.300 99.792 58.749
201603 58.416 100.470 75.248
201606 60.113 101.688 76.506
201609 116.351 101.861 147.830
201612 66.580 101.863 84.592
201703 86.335 102.862 108.625
201706 117.065 103.349 146.595
201709 -3.505 104.136 -4.356
201712 -61.747 104.011 -76.831
201803 54.402 105.290 66.870
201806 157.122 106.317 191.265
201809 268.633 106.507 326.424
201812 260.165 105.998 317.652
201903 437.808 107.251 528.304
201906 460.194 108.070 551.109
201909 413.852 108.329 494.422
201912 549.917 108.420 656.427
202003 782.073 108.902 929.422
202006 807.828 108.767 961.214
202009 861.184 109.815 1,014.925
202012 -675.454 109.897 -795.445
202103 1,126.000 111.754 1,303.987
202106 577.853 114.631 652.399
202109 1,760.040 115.734 1,968.157
202112 1,494.652 117.630 1,644.460
202203 1,825.325 121.301 1,947.490
202206 1,865.115 125.017 1,930.797
202209 1,778.560 125.227 1,838.111
202212 1,978.270 125.222 2,044.584
202303 2,192.805 127.348 2,228.476
202306 -5,640.000 128.729 -5,670.262
202309 6,509.070 129.860 6,487.010
202312 -1,732.800 129.419 -1,732.800

Add all the adjusted EPS together and divide 10 will get our E10.

Please note that we use the CPI data of the country/region where the company is headquartered. If the CPI data for that country/region is not available, then we will use the CPI data of the United States as default.


Merck  (BUE:MRK) Shiller PE Ratio Explanation

Compared with the regular PE Ratio, which works poorly for cyclical businesses, the Shiller PE Ratio smoothed out the fluctuations of profit margins during business cycles. Therefore it is more accurate in reflecting the valuation of the company.

If a company has consistent business performance, the Shiller PE Ratio should give similar results to regular PE Ratio.

Compared with the PS Ratio, the Shiller PE Ratio makes the comparison between different industries more meaningful.


Be Aware

Shiller PE Ratio assumes that over the long term, businesses and profitability revert to their means. If a company's business model does not work in the future compared with the past, Shiller PE Ratio and PS Ratio will give false valuations.


Merck Shiller PE Ratio Related Terms

Thank you for viewing the detailed overview of Merck's Shiller PE Ratio provided by GuruFocus.com. Please click on the following links to see related term pages.


Merck (BUE:MRK) Business Description

Address
126 East Lincoln Avenue, Rahway, NJ, USA, 07065
Merck makes pharmaceutical products to treat several conditions in a number of therapeutic areas, including cardiometabolic disease, cancer, and infections. Within cancer, the firm's immuno-oncology platform is growing as a major contributor to overall sales. The company also has a substantial vaccine business, with treatments to prevent pediatric diseases as well as human papillomavirus, or HPV. Additionally, Merck sells animal health-related drugs. From a geographical perspective, just under half of the company's sales are generated in the United States.

Merck (BUE:MRK) Headlines

From GuruFocus

Merck & Co Inc at UBS BioPharma Conference Transcript

By GuruFocus Research 01-23-2024

Q1 2023 Merck & Co Inc Earnings Call Transcript

By GuruFocus Research 01-23-2024

Merck & Co Inc at Citi BioPharma Conference Transcript

By GuruFocus Research 01-23-2024

Q4 2022 Merck & Co Inc Earnings Call Transcript

By GuruFocus Research 01-23-2024

Merck & Co Inc Annual Shareholders Meeting Transcript

By GuruFocus Research 01-23-2024